Journal
ONCOGENE
Volume 29, Issue 33, Pages 4671-4681Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2010.217
Keywords
lung cancer; cancer stem cell; DEK; neuroendocrine
Funding
- Ministry of Health, Labor and Welfare of Japan
- New Energy and Industrial Technology Development Organization (NEDO), Japan
- National Institute of Biomedical Innovation (NiBio)
Ask authors/readers for more resources
Lung cancer shows diverse histological subtypes. Large-cell neuroendocrine cell carcinoma and small-cell lung carcinoma show similar histological features and clinical behaviors, and can be classified as high-grade neuroendocrine carcinoma (HGNEC) of the lung. Here we elucidated the molecular classification of pulmonary endocrine tumors by copy-number profiling. We compared alterations of copy number with the clinical outcome of HGNEC and identified a chromosomal gain of the DEK oncogene locus (6p22.3) that was significantly associated with poor prognosis. We further confirmed that DEK overexpression was associated with poor prognosis in a larger set of HGNEC. Downregulation of DEK by small hairpin RNA led to a marked reduction of in vitro colony formation, in vivo tumorigenicity and chemo-resistance, and was associated with loss of lung cancer stem cell markers. Gene expression profiling revealed that DEK downregulation was associated with altered expression of transcriptional regulators, which specifically include known targets of interchromosomal translocations in hematopoietic tumors, and knockdown of these epigenetic modifiers affected colony formation activity. Our study showed that DEK overexpression, partly through an increase in its gene dose, mediates the activity of global transcriptional regulators and is associated with tumor initiation activity and poor prognosis in HGNEC. Oncogene (2010) 29, 4671-4681; doi:10.1038/onc.2010.217; published online 14 June 2010
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available